Salva Health wants to lower breast cancer mortality with its affordable screening device

Valentina Agudelo identified a troubling gap in breast cancer survival rates between Latin America and the developed world, with women in her native Colombia and the rest of the continent dying at higher rates due to late detection. So she founded Salva Health and began developing the company’s first product, Julietta, a small device that measures tissue density with electrodes that attach to each breast and provides results within minutes to a phone, tablet or computer. She pitched the device onstage at Startup Battlefield.

Salva Health
Salva HealthImage Credits:Salva Health
October 30, 2024 – October 30, 2024

From the Storyline: TechCrunch Disrupt 2024: Tony Fadell, Mary Barra, Colin Kaepernick, and a new Startup Battlefield winner

TechCrunch Disrupt 2024 has begun, with hundreds of speakers, hundreds of startups and exhibitors, plus thousands of attendees meeting in…

Latest in Biotech & Health